Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

An Analysis of Over-the-Counter Cannabidiol Products in the United Kingdom
Jonathan Paul Liebling, Nicholas James Clarkson, Blair William Gibbs, et al.
Cannabis and Cannabinoid Research (2020) Vol. 7, Iss. 2, pp. 207-213
Open Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Cannabidiol: pharmacology and therapeutic targets
Stevie C. Britch, Shanna Babalonis, Sharon Walsh
Psychopharmacology (2020) Vol. 238, Iss. 1, pp. 9-28
Open Access | Times Cited: 224
Reasons for cannabidiol use: a cross-sectional study of CBD users, focusing on self-perceived stress, anxiety, and sleep problems
Julie Moltke, Chandni Hindocha
Journal of Cannabis Research (2021) Vol. 3, Iss. 1
Open Access | Times Cited: 113
THC and CBD: Similarities and differences between siblings
Nephi Stella
Neuron (2023) Vol. 111, Iss. 3, pp. 302-327
Open Access | Times Cited: 61
Conversion of Cannabidiol (CBD) into Psychotropic Cannabinoids Including Tetrahydrocannabinol (THC): A Controversy in the Scientific Literature
Patricia Golombek, Marco Müller, Ines Barthlott, et al.
Toxics (2020) Vol. 8, Iss. 2, pp. 41-41
Open Access | Times Cited: 118
Palmitoylethanolamide: A Natural Compound for Health Management
Paul Clayton, Mariko Hill, Nathasha Bogoda, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5305-5305
Open Access | Times Cited: 94
Access to cannabidiol without a prescription: A cross-country comparison and analysis
Iain S. McGregor, Elizabeth A. Cairns, Sarah V. Abelev, et al.
International Journal of Drug Policy (2020) Vol. 85, pp. 102935-102935
Open Access | Times Cited: 82
Content versus Label Claims in Cannabidiol (CBD)-Containing Products Obtained from Commercial Outlets in the State of Mississippi
Bill J. Gurley, Timothy F. Murphy, Waseem Gul, et al.
Journal of Dietary Supplements (2020) Vol. 17, Iss. 5, pp. 599-607
Closed Access | Times Cited: 79
Evaluation of dispensaries’ cannabis flowers for accuracy of labeling of cannabinoids content
Mona M. Geweda, Chandrani G. Majumdar, Malorie N Moore, et al.
Journal of Cannabis Research (2024) Vol. 6, Iss. 1
Open Access | Times Cited: 11
Product labeling accuracy and contamination analysis of commercially available cannabidiol product samples
Barry E. Gidal, Ryan G. Vandrey, Chela Wallin, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 11
Validated LC-MS/MS methodology for the quantification of CBD, trace level THCA and UK controlled cannabinoids (Δ9THC, Δ8THC, CBN and THCV) in food samples
Tabatha Hambidge, Ralph G. Nash, Steve Corless, et al.
Analytical Methods (2025)
Open Access | Times Cited: 1
Cannabidiol (CBD) product contamination: Quantitative analysis of Δ9-tetrahydrocannabinol (Δ9-THC) concentrations found in commercially available CBD products
Erin M. Johnson, Michael Kilgore, Shanna Babalonis
Drug and Alcohol Dependence (2022) Vol. 237, pp. 109522-109522
Open Access | Times Cited: 36
Label accuracy of unregulated cannabidiol (CBD) products: measured concentration vs. label claim
Erin M. Johnson, Michael Kilgore, Shanna Babalonis
Journal of Cannabis Research (2022) Vol. 4, Iss. 1
Open Access | Times Cited: 35
A survey of cannabinoids and toxic elements in hemp-derived products from the United States marketplace
Geoffrey A. Dubrow, Rahul S. Pawar, Cynthia T. Srigley, et al.
Journal of Food Composition and Analysis (2021) Vol. 97, pp. 103800-103800
Open Access | Times Cited: 37
Fabrication and characterization of a cannabidiol-loaded emulsion stabilized by a whey protein-maltodextrin conjugate and rosmarinic acid complex
Ce Wang, Ji Li, Yonghai Sun, et al.
Journal of Dairy Science (2022) Vol. 105, Iss. 8, pp. 6431-6446
Open Access | Times Cited: 25
Skin applications of cannabidiol: sources, effects, delivery systems, marketed formulations and safety
Beatriz Pires Ferreira, Gustavo Costa, Filipa Mascarenhas‐Melo, et al.
Phytochemistry Reviews (2023) Vol. 22, Iss. 3, pp. 781-828
Open Access | Times Cited: 16
Stability, biofunctional, and antimicrobial characteristics of cannabidiol isolate for the design of topical formulations
Sreejarani Kesavan Pillai, Nazia H. Kera, Phumelele Kleyi, et al.
Soft Matter (2024) Vol. 20, Iss. 10, pp. 2348-2360
Open Access | Times Cited: 5
Could Cannabidiol Be a Treatment for Coronavirus Disease-19-Related Anxiety Disorders?
Saoirse E. O’Sullivan, Carl W. Stevenson, Steven R. Laviolette
Cannabis and Cannabinoid Research (2020) Vol. 6, Iss. 1, pp. 7-18
Open Access | Times Cited: 33
Impact of carrier oil on interfacial properties, CBD partition and stability of emulsions formulated by whey protein or whey protein-maltodextrin conjugate
Ce Wang, Xiaoge Zhang, Ru Zhao, et al.
LWT (2022) Vol. 168, pp. 113933-113933
Open Access | Times Cited: 22
Using Social Media Data to Investigate Public Perceptions of Cannabis as a Medicine: Narrative Review
Sedigh Khademi, Christine Mary Hallinan, Mike Conway, et al.
Journal of Medical Internet Research (2023) Vol. 25, pp. e36667-e36667
Open Access | Times Cited: 13
The analysis of cannabinoids in e-cigarette liquids using LC-HRAM-MS and LC-UV
Sophia Barhdadi, P. Courselle, Eric Deconinck, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 230, pp. 115394-115394
Closed Access | Times Cited: 12
Pain response to cannabidiol in opioid-induced hyperalgesia, acute nociceptive pain, and allodynia using a model mimicking acute pain in healthy adults in a randomized trial (CANAB II)
Markus Dieterle, Laura Zurbriggen, Eckhard Mauermann, et al.
Pain (2022) Vol. 163, Iss. 10, pp. 1919-1928
Open Access | Times Cited: 19
Cannabidiol drug interaction considerations for prescribers and pharmacists
Myfanwy Graham, Jennifer Martin, Catherine Lucas, et al.
Expert Review of Clinical Pharmacology (2022) Vol. 15, Iss. 12, pp. 1383-1397
Open Access | Times Cited: 17
Challenges of cannabidiol determination in emulsified cosmetics and application of solid-phase extraction followed by HPLC-UV-MS/MS
Magdaléna Vágnerová, David Sýkora, Alžběta Nemeškalová, et al.
Analytical and Bioanalytical Chemistry (2025)
Closed Access
Over the counter CBD products in Germany: an exploratory survey about consumption patterns and health related effects
Anaelle Weissgerber, Maren Hermanns‐Clausen, Evelyn Lamy
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Lack of evidence for the effectiveness or safety of over-the-counter cannabidiol products
Edward Chesney, Philip McGuire, Tom P. Freeman, et al.
Therapeutic Advances in Psychopharmacology (2020) Vol. 10
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top